mortality/aging
N |
• females develop and live normally, and are free of lymphoproliferative disease
|
immune system
• mice have a 4-fold increase in numbers of late apoptotic cells among EGFP+ CD4+ single positive thymocytes relative to controls
• EGFP+ T cells show more apoptosis than EGFP- T cells from the same mouse, or EGFP+ and EGFP-T cells from controls
|
• peripheral lymphoid tissues of females have fewer EGFP+ T cells than controls
|
• females have a lower percentage of EGFP+ CD4+ single positive thymocytes in the periphery compared to controls
|
• in response to stimulation, EGFP+ CD4+ T cells show substantial proliferation whereas cells from Foxp3tm2Tch females do not proliferate
|
hematopoietic system
• mice have a 4-fold increase in numbers of late apoptotic cells among EGFP+ CD4+ single positive thymocytes relative to controls
• EGFP+ T cells show more apoptosis than EGFP- T cells from the same mouse, or EGFP+ and EGFP-T cells from controls
|
• peripheral lymphoid tissues of females have fewer EGFP+ T cells than controls
|
• females have a lower percentage of EGFP+ CD4+ single positive thymocytes in the periphery compared to controls
|
• in response to stimulation, EGFP+ CD4+ T cells show substantial proliferation whereas cells from Foxp3tm2Tch females do not proliferate
|
cellular
• mice have a 4-fold increase in numbers of late apoptotic cells among EGFP+ CD4+ single positive thymocytes relative to controls
• EGFP+ T cells show more apoptosis than EGFP- T cells from the same mouse, or EGFP+ and EGFP-T cells from controls
|
endocrine/exocrine glands
• females have a lower percentage of EGFP+ CD4+ single positive thymocytes in the periphery compared to controls
|